ID21338A - Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan - Google Patents

Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan

Info

Publication number
ID21338A
ID21338A IDW990061A ID990061A ID21338A ID 21338 A ID21338 A ID 21338A ID W990061 A IDW990061 A ID W990061A ID 990061 A ID990061 A ID 990061A ID 21338 A ID21338 A ID 21338A
Authority
ID
Indonesia
Prior art keywords
protozoa
live bacteria
produce active
active immune
subject
Prior art date
Application number
IDW990061A
Other languages
English (en)
Inventor
John A Thoma
Eid E Haddad
Craig E Whitfill
Alan P Avakian
Original Assignee
Embrex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embrex Inc filed Critical Embrex Inc
Publication of ID21338A publication Critical patent/ID21338A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW990061A 1996-09-30 1997-09-26 Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan ID21338A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2708496P 1996-09-30 1996-09-30

Publications (1)

Publication Number Publication Date
ID21338A true ID21338A (id) 1999-05-27

Family

ID=21835595

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990061A ID21338A (id) 1996-09-30 1997-09-26 Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan

Country Status (17)

Country Link
US (2) US6440408B2 (id)
EP (1) EP0951299B1 (id)
JP (1) JP4113588B2 (id)
KR (1) KR100382224B1 (id)
CN (1) CN100389827C (id)
AT (1) ATE272409T1 (id)
AU (1) AU715555B2 (id)
BR (1) BR9713312B1 (id)
CA (1) CA2264810C (id)
CZ (1) CZ94899A3 (id)
DE (1) DE69730152T2 (id)
EA (1) EA199900342A1 (id)
ES (1) ES2224273T3 (id)
ID (1) ID21338A (id)
IL (1) IL128014A (id)
PL (1) PL332540A1 (id)
WO (1) WO1998014212A1 (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202484T1 (de) 1995-06-07 2001-07-15 Pfizer In ovo impfung gegen coccidiose
EP0831897B1 (en) 1995-06-07 2001-03-28 Pfizer Inc. In ovo vaccination against coccidiosis
US6969520B2 (en) 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
DE19828322A1 (de) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
BR0210804A (pt) 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
KR20040021678A (ko) 2001-08-30 2004-03-10 엠브렉스, 인코포레이티드 난포낭을 생산하기 위한 개선된 방법
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
ATE526033T1 (de) * 2002-05-21 2011-10-15 Schering Plough Ltd Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US8092808B2 (en) * 2003-12-03 2012-01-10 Pfizer, Inc. Ovo vaccination of Campylobacter in avian species
KR20120042865A (ko) * 2006-03-30 2012-05-03 엠브렉스, 인코포레이티드 가금류의 예방접종 방법 및 조성물
US8040266B2 (en) 2007-04-17 2011-10-18 Cypress Semiconductor Corporation Programmable sigma-delta analog-to-digital converter
EP2164511A1 (en) * 2007-05-22 2010-03-24 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
EP4365196A3 (en) 2011-04-22 2024-08-07 Wyeth LLC Compositions relating to a mutant clostridium difficile toxin and methods thereof
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
US10335484B2 (en) 2013-01-08 2019-07-02 Humabs Biomed Sa Methods of generating robust passive and active immune responses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105136A (en) 1964-03-25 1968-03-06 Wellcome Found Vaccines comprising living protozoa of the genus theileria
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
EP0256878B1 (en) 1986-08-18 1993-04-14 Btg International Limited Vaccines
US4935007A (en) 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5026636A (en) * 1987-11-10 1991-06-25 The University Of Texas Board Of Regents Methods and compositions for production of mycoplasmal adhesins
DE3921255A1 (de) 1989-06-29 1991-01-03 Krebsoege Gmbh Sintermetall Verfahren zur erzeugung eines in einem traegergasstrom foerderbaren fluessigkeitsnebels und vorrichtung zur durchfuehrung des verfahrens
US5397568A (en) 1989-10-02 1995-03-14 Whitfill; Craig E. Method of treating infectious bursal disease virus infections
WO1991004750A1 (en) 1989-10-02 1991-04-18 Embrex, Inc. Method of treatment
DE69030383T2 (de) 1989-10-02 1997-10-23 Univ Arkansas Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
CH682455A5 (fr) 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
US5378820A (en) * 1992-11-09 1995-01-03 Keeler; Calvin L. Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use
US5641491A (en) * 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
ATE202484T1 (de) 1995-06-07 2001-07-15 Pfizer In ovo impfung gegen coccidiose
BR9708387A (pt) * 1996-03-28 2000-01-04 Genitrix Llc Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.

Also Published As

Publication number Publication date
KR100382224B1 (ko) 2003-04-26
KR20000048622A (ko) 2000-07-25
DE69730152T2 (de) 2005-11-03
IL128014A0 (en) 1999-11-30
CN100389827C (zh) 2008-05-28
AU4595397A (en) 1998-04-24
US20020015706A1 (en) 2002-02-07
EA199900342A1 (ru) 1999-10-28
PL332540A1 (en) 1999-09-13
DE69730152D1 (de) 2004-09-09
BR9713312B1 (pt) 2009-08-11
ATE272409T1 (de) 2004-08-15
EP0951299B1 (en) 2004-08-04
JP4113588B2 (ja) 2008-07-09
CN1231614A (zh) 1999-10-13
AU715555B2 (en) 2000-02-03
CA2264810C (en) 2010-07-27
CA2264810A1 (en) 1998-04-09
ES2224273T3 (es) 2005-03-01
IL128014A (en) 2003-11-23
CZ94899A3 (cs) 1999-09-15
US6440408B2 (en) 2002-08-27
BR9713312A (pt) 2000-02-01
US6890527B2 (en) 2005-05-10
WO1998014212A1 (en) 1998-04-09
EP0951299A1 (en) 1999-10-27
US20030044414A1 (en) 2003-03-06
JP2000507608A (ja) 2000-06-20

Similar Documents

Publication Publication Date Title
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
MY125202A (en) Vaccine
NO950881L (no) Nöytraliserende monoklonale menneske-antistoffer mot respiratorisk syncytialt virus
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
ZA964822B (en) Antigenic group b streptococcus type ii and type iii polysaccharide- fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
EP0495008A4 (en) Method of treatment
CA2040374A1 (en) Process for enhancing the resistance of aquatic animals to disease
AP2000001886A0 (en) Group B streptococcus antigens.
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
DE69928523D1 (de) Verotoxin b untereinheit zur immunisierunug
NO940827D0 (no) Parenteral immunisering mot rotavirus
AU6176596A (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
HUP9902513A2 (hu) Aktív immunitás létrehozására szolgáló vakcinakonjugátumok
RU94033173A (ru) Способ повышения репродуктивной функции мужчин
RU95104722A (ru) Способ получения антител к коринебактериям дифтерии